Cargando…
Secondary findings in inherited heart conditions: a genotype-first feasibility study to assess phenotype, behavioural and psychosocial outcomes
Disclosing secondary findings (SF) from genome sequencing (GS) can alert carriers to disease risk. However, evidence around variant-disease association and consequences of disclosure for individuals and healthcare services is limited. We report on the feasibility of an approach to identification of...
Autores principales: | Ormondroyd, Elizabeth, Harper, Andrew R., Thomson, Kate L., Mackley, Michael P., Martin, Jennifer, Penkett, Christopher J., Salatino, Silvia, Stark, Hannah, Stephens, Jonathan, Watkins, Hugh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576165/ https://www.ncbi.nlm.nih.gov/pubmed/32686758 http://dx.doi.org/10.1038/s41431-020-0694-9 |
Ejemplares similares
-
Stakeholder views on secondary findings in whole-genome and whole-exome
sequencing: a systematic review of quantitative and qualitative studies
por: Mackley, Michael P., et al.
Publicado: (2017) -
Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study
por: Mackley, Michael P, et al.
Publicado: (2018) -
Do health professionals value genomic testing? A discrete choice experiment in inherited cardiovascular disease
por: Buchanan, James, et al.
Publicado: (2019) -
“Not pathogenic until proven otherwise”: perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project
por: Ormondroyd, Elizabeth, et al.
Publicado: (2017) -
Data-driven modelling of mutational hotspots and in silico predictors in hypertrophic cardiomyopathy
por: Waring, Adam, et al.
Publicado: (2021)